Paloma Partners’s Cardiovascular Systems, Inc. CSII Stock Holding History

Paloma Partners’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-19,273	Closed	-$362K	–	2399
2021 Q4	$362K	Buy	+19,273	New	+$515K	0.01%	1305
2018 Q4	–	Sell	-5,147	Closed	-$202K	–	1880
2018 Q3	$202K	Buy	+5,147	New	+$190K	﹤0.01%	1392
2017 Q3	–	Sell	-16,130	Closed	-$519K	–	2540
2017 Q2	$519K	Sell	16,130 -10,350	-39%	-$315K	0.01%	1525
2017 Q1	$749K	Buy	+26,480	New	+$703K	0.01%	1408
2016 Q4	–	Sell	-15,008	Closed	-$357K	–	2202
2016 Q3	$357K	Buy	+15,008	New	+$329K	﹤0.01%	1558
2015 Q3	–	Sell	-18,581	Closed	-$491K	–	2018
2015 Q2	$491K	Buy	+18,581	New	+$600K	0.01%	1100

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Paloma Partners's CSII Position: Q1 2022 in Review

Paloma Partners sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2022, closing a stake of 19,273 shares — an estimated $362K sold.

Paloma Partners first reported a position in CSII in Q2 2015 and held it in 6 quarters. The position peaked at $749K in Q1 2017. 174 funds tracked by Wall St. Rank hold CSII as of Q1 2022.

Paloma Partners reported no remaining Cardiovascular Systems, Inc. position as of Q1 2022 after selling out during the quarter.
Paloma Partners sold 19,273 Cardiovascular Systems, Inc. shares in Q1 2022, an estimated $362K.
Paloma Partners first reported a position in Cardiovascular Systems, Inc. in Q2 2015 and held it in 6 quarters.
Paloma Partners's Cardiovascular Systems, Inc. position peaked at $749K in Q1 2017.
174 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2022.

Based on Paloma Partners's 13F filing for Q1 2022, filed 16 May 2022.